Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2005-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The surgical technique is based on locating the INTACS inserts on the flattest axis of the refractive error, making the incision on the steepest axis, using 150 degree arc length inserts with different sizes (0.250, 0.300, 0.350, 0.400 \& 0.450 mm) according to a nomogram designed for this technique using the INTACS Instrumentation (10-Step Prolate System instruments).
The corneal lamellar channel creation may be performed using the INTACS instrumentation or using the Femtosecond laser (Femtec 20/10 laser\[Femtec,Heidelberg Germany\])
Primary Assessment Criteria
* Evaluation of the safety of the device for the treatment of patients with keratoconus (mild to moderate)
* Maintenance of best corrected visual acuity (BCVA)
* Improvement in uncorrected visual acuity (UCVA)
* Reduction in manifest refraction spherical equivalent
* Reduction in asymmetric astigmatism
Secondary Assessment Criteria
* Evaluation of the effect of INTACS inserts placement for treatment of corneal ectasia
* Determination of patient satisfaction following the INTACS inserts procedure Patients meeting the eligibility criteria are required to sign a Patient Informed Consent Form prior to study participation.
A thorough examination is perform to evaluate the following:
* Manifest refraction results - Uncorrected visual acuity (UCVA) and best corrected visual acuity (BCVA)
* Cycloplegic refraction results - Uncorrected visual acuity (UCVA) and best corrected visual acuity (BCVA)
* Corneal topography
* Pachymetry
* Step axis location
* Location of incision placement
* Subjective feedback about quality of vision (Excellent, Good, Fair and Poor)
Post-operative Assessment(at 1 day, 1 week, 1 month and 3 months postop)
* Uncorrected visual acuity (UCVA) and best corrected visual acuity with manifest refraction(BCVA) at designated time interval
* Cycloplegic refraction results - Uncorrected visual acuity (UCVA) and best corrected visual acuity (BCVA) at designated time interval
* Corneal topography at designated time interval
* Pachymetry at designated time interval
* Subjective visual outcome ratings over time (Excellent, Good, Fair and Poor)
* Report adverse events
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intacs intracorneal ring insertion for the treatment of keratoconus
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Visual acuity with contact lenses must be better than or equal to (20/40).
* Patients must be intolerant of contact lenses, i.e., they must be unable to wear contact lenses for a whole day.
* Patients will have a corneal thickness of 425 microns at the site of ICRS (INTACS inserts) placement (the thinnest region of the cornea).
* In terms of general health, patients must not have any illnesses posing an immediate threat to life.
* Patients must have provided written informed consent at least one week prior to surgery.
* Patients must over 21 years of age.
* Patients' contact lenses must have been removed at least one week prior to surgery for soft lenses and two weeks prior to surgery for hard lenses.
Exclusion Criteria
* Breast-feeding.
* History of previous ophthalmologic surgery on the operative eye.
* Patients with corneal stromal disorders.
* Patients with history of herpetic keratitis.
* Patients with retinal disorders.
* Corneal grafts.
* Patients refusing to remove contact lenses one week before surgery for soft lenses and two weeks before surgery for hard lenses.
* Patients with amblyopia (VA \<1110 for the contralateral eye).
* Patients with corneal thickness \<425 microns.
* Patients with TOP \<10 mmHg or \>21 mmHg.
* Patients taking part in other biomedical research in the 30 days prior to the start of this study.
* Patients with an uncooperative disposition.
21 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Singapore National Eye Centre
OTHER_GOV
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Donald TH Tan, FRCS
Role: PRINCIPAL_INVESTIGATOR
Singapore National Eye Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Singapore National Eye Centre
Singapore, , Singapore
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Colin J, Cochener B, Savary G, Malet F, Holmes-Higgin D. INTACS inserts for treating keratoconus: one-year results. Ophthalmology. 2001 Aug;108(8):1409-14. doi: 10.1016/s0161-6420(01)00646-7.
Colin J, Cochener B, Savary G, Malet F. Correcting keratoconus with intracorneal rings. J Cataract Refract Surg. 2000 Aug;26(8):1117-22. doi: 10.1016/s0886-3350(00)00451-x.
Siganos D, Ferrara P, Chatzinikolas K, Bessis N, Papastergiou G. Ferrara intrastromal corneal rings for the correction of keratoconus. J Cataract Refract Surg. 2002 Nov;28(11):1947-51. doi: 10.1016/s0886-3350(02)01495-5.
Schanzlin DJ, Asbell PA, Burris TE, Durrie DS. The intrastromal corneal ring segments. Phase II results for the correction of myopia. Ophthalmology. 1997 Jul;104(7):1067-78. doi: 10.1016/s0161-6420(97)30183-3.
Siganos CS, Kymionis GD, Kartakis N, Theodorakis MA, Astyrakakis N, Pallikaris IG. Management of keratoconus with Intacs. Am J Ophthalmol. 2003 Jan;135(1):64-70. doi: 10.1016/s0002-9394(02)01824-x.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R419/14/2005
Identifier Type: -
Identifier Source: org_study_id